Chinese Journal of Clinical Infectious Diseases

Items 1-5 of 19
«Preious | of 4 | Next»
1

Combination therapy will be the future for the antiviral treatment of chronic hepatitis B

Chinese Journal of Clinical Infectious Diseases, Volume 05, Issue 03,2012, Pages 129-130, Dol:10.3760/cma.j.issn.1674-2397.2012.03.001

2

A 96-week comparison of de novo combination therapy with lamivudine and adefovir dipivoxil to optimization monotherapy for chronic hepatitis B

Chinese Journal of Clinical Infectious Diseases, Volume 05, Issue 03,2012, Pages 131-136, Dol:10.3760/cma.j.issn.1674-2397.2012.03.002

3

De novo combination with lamivudine and adefovir dipivoxil versus entecavir monotherapy for naive patients with hepatitis B virus-related decompensated cirrhosis: a 2-year study

Chinese Journal of Clinical Infectious Diseases, Volume 05, Issue 03,2012, Pages 137-141, Dol:10.3760/cma.j.issn.1674-2397.2012.03.003

4

De novo combination therapy with lamivudine and adefovir dipivoxil versus entecavir monotherapy for na(i)ve chronic hepatitis B patients with high viral loads

Chinese Journal of Clinical Infectious Diseases, Volume 05, Issue 03,2012, Pages 142-144, Dol:10.3760/cma.j.issn.1674-2397.2012.03.004

5

In vitro effect of human amniotic fluid-derived mesenchymal stem cells on Th1/Th2 ratio in peripheral blood of hepatitis B patients with liver failure

Chinese Journal of Clinical Infectious Diseases, Volume 05, Issue 03,2012, Pages 145-148, Dol:10.3760/cma.j.issn.1674-2397.2012.03.005

Items 1-5 of 19
«Preious | of 4 | Next»
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn